Report
Jeanie Chen
EUR 850.00 For Business Accounts Only

Morningstar | Launching Coverage of Kirin HD With Narrow Moat and Negative Moat Trend Ratings, FVE of JPY 2,600. See Updated Analyst Note from 07 Jul 2019

We initiate coverage of Japanese leading brewers Asahi Group Holdings (Asahi) and Kirin Holdings (Kirin), and assign both names with narrow moat and negative moat trend ratings. We view Asahi as undervalued with a healthy upside of 24% to our fair value estimate of JPY 6,000 and Kirin as fairly valued with a modest 10% upside to our fair value estimate of JPY 2,600. The secular decline in beer and beer-like volumes seems unlikely to be reversed. However, the coming liquor tax revisions will offer brewers opportunities to not only cease volume contraction but lift the profit margins of beer.

We consider the brewing businesses of Asahi and Kirin to have a narrow moat underpinned by a cost advantage and intangible assets. Specifically, local economies of scale enable meaningful cost savings through the optimization of production and logistics in the core operating markets because of the capital-intensive nature of the brewing business and a sizable weight of transportation costs. The scale further empowers investment in brand building and product development, and acquisition, which reinforces its brand equity and enriches the brand/ product portfolios. The moat trend is turning negative as the secular volume decline in beer and beer-like drinks in Japan and some core markets in developed countries will eventually impair cost advantages and investment returns when there is limited room to increase profit margins.

Establishing itself in the global premium beer market by leveraging SABMiller’s European brand portfolio and distribution capabilities to grow the Asahi Super Dry brand, will support Asahi’s long-term growth. We project a 3.2% EPS CAGR over the next five years based on the its overseas expansion in premium markets combined with introduction of the zero-based budgeting will lift overseas top-line growth and group-wide margins. The beer tax cuts in Japan will also work in favor of Asahi’s leading share position in the beer category.

Contrary to Asahi’s focus on beer, Kirin is seeking new revenue streams in the wellness industry. It is looking to develop proprietary products and services for health management and disease prevention by leveraging its know-how in consumer products and Kyowa Hakko Kirin’s expertise in pharmaceuticals. Nevertheless, margin expansion of the lucrative brewery business combined with expansion of the pharmaceutical sales abroad will remain the mid-term profit drivers, sustaining a 3% CAGR in Kirin’s operating profits excluding charges over the next five years.

We consider Asahi the beneficiary of the planned liquor tax reform in Japan, beginning in October 2020 with multistage tax revisions through October 2026. We believe excise tax cuts in beer and tax hikes on the beer-like drinks will cease the ongoing volume contraction of beer. Moreover, tax cuts offer brewers rare opportunities to hike beer prices, allowing Asahi to fully offset the profit decline caused by shrinking beer-like demand, estimated at JPY 17 billion over seven years. Please refer to our report of “Liquor tax reforms turning the tables on Japan’s brewing market” for more details in Japan’s brewing industry and the financial effects of the tax reforms on Asahi and Kirin.
Underlying
Kirin Holdings Company Limited

Kirin Holdings is a holding company. Co., through its affiliates, is mainly engaged in the manufacture and sale of alcoholic beverages, soft drinks and foods. Co.'s products include low-alcohol (less than 10%) beverages of beer, happoshu (low-malt beer), new genre, chu-hai (cocktail of shochu with tonic water) drinks and non-alcohol of beer "Kirin FREE," as well as spirits, wine and other liquors; tea drinks in PET bottles, canned coffee, health drinks to provide amino acids, as well as lemon and other fruit drinks; and milk, dairy products, seasonings, freeze-dried soup and other functional foods. Co. is also involved in the manufacture and sale of pharmaceutical products.

Provider
Morningstar
Morningstar

Morningstar, Inc. is a leading provider of independent investment research in North America, Europe, Australia, and Asia. The company offer an extensive line of products and services for individual investors, financial advisors, asset managers, and retirement plan providers and sponsors.

Morningstar provides data on approximately 530,000 investment offerings, including stocks, mutual funds, and similar vehicles, along with real-time global market data on more than 18 million equities, indexes, futures, options, commodities, and precious metals, in addition to foreign exchange and Treasury markets. Morningstar also offers investment management services through its investment advisory subsidiaries and had approximately $185 billion in assets under advisement and management as of June 30, 2016.

We have operations in 27 countries.

Analysts
Jeanie Chen

Other Reports on these Companies
Other Reports from Morningstar

ResearchPool Subscriptions

Get the most out of your insights

Get in touch